Từ khóa: #Nanocovax

Nanocovax vaccine has met the short-term safety requirement based on the reporting result of the phase 3 mid-term clinical trial. The evaluation of efficacy was carried out among 11,430 volunteers within seven days after receiving the first shot and 5,785 people within seven days after getting the second dose, announced the Ministry of Health on September 19.

In the evening of September 18, the National Ethics Committee in Biomedical Research under the Ministry of Health (MoH) approved the clinical trial results of the phase 3 of Nanocovax, a home-grown Covid-19 vaccine.

The National Ethics Committee in Biomedical Research under the Ministry of Health (MoH) has just approved the clinical trial results of the phase 3a mid-term of Nanocovax, a home-grown Covid-19 vaccine.

State President Nguyen Xuan Phuc on July 29 urged Ho Chi Minh City – the country’s biggest Covid-19 hotspot at present - to promote the motto of “fighting the pandemic is like fighting the enemy.”

Twenty volunteers received the second shots of Nanocovax - a Vietnam-developed COVID-19 vaccine at the Military Medical University on January 20.

The Institute of Vaccines and Medical Biologicals (IVAC), based in central Khanh Hoa province, has proposed the Ministry of Health allow human trials of its COVID-19 vaccine to begin in January, two months ahead of schedule.